会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Multipurpose antibody derivatives
    • 多用抗体衍生物
    • US06809185B1
    • 2004-10-26
    • US09625049
    • 2000-07-24
    • Reinhilde SchoonjansNico MertensWalter FiersRoland Contreras
    • Reinhilde SchoonjansNico MertensWalter FiersRoland Contreras
    • C07K1600
    • C07K16/2809A61K38/00C07K16/00C07K16/40C07K16/468C07K2317/73C07K2319/00
    • The present invention relates to a class of molecules specified as novel multipurpose antibody derivatives. This class of molecules is created by heterodimerization of two constituting components. Heterodimerization is obtained by the specific heterotypic interaction of a chosen VH-CH1 combination of immunoglobulin domains, with a chosen VL-CL combination of immunoglobulin domains. The appropriate VH and VL domains in the VHCH1 and VLCL context, a binding specificity can be constitituted by the heterodimerization scaffold itself. One or both of the comprising VHCH1 and VLCL chains can thus be extended at either the N- or the C-terminus or both with other molecules, such as a toxin polypeptide, an enzyme, a hormone, a cytokine, a signaling molecule, or a single chain linked Fv fragment with the same or a different specificity.
    • 本发明涉及一类被指定为新型多功能抗体衍生物的分子。 这类分子是由两种构成成分的异二聚化产生的。 通过选择的免疫球蛋白结构域的VH-CH1组合与选择的免疫球蛋白结构域的VL-CL组合的特异性异型相互作用获得异二聚化。 VHCH1和VLCL环境中适当的VH和VL结构域,结合特异性可以由异二聚化支架本身构成。 因此,包含VHCH1和VLCL链的一个或两个可以在N-或C-末端延伸,或者与其它分子例如毒素多肽,酶,激素,细胞因子,信号传导分子或 具有相同或不同特异性的单链连接的Fv片段。